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R271Replication: DNA Building Block
Synthesis On DemandCorrect regulation of DNA nucleotide biosynthesis is emerging as a key issue of
importance for genome integrity. Thefission yeastSpd1proteincanmodulate the
activity of ribonucleotide reductase (RNR) by at least threedifferentmechanisms.
Now a paper reports that Spd1 turnover is linked to ongoing DNA synthesis.Christian Holmberg and Olaf Nielsen*
According to current thinking in the
field [1] cancer development can be
initiated by special ‘oncogenic’
S phases, where mutations in
proto-oncogenes cause replication
stress. This in turn may lead to
replication fork collapse and the
generation of DNA double strand
breaks (DSBs). In order to prevent
tumor progression, the organism relies
on p53-mediated senescence or
apopotosis in such precancerous cells.
Cancer develops when this barrier
breaks down bymutational inactivation
of the DNA damage response pathway.
The exact mechanisms by which
oncogene activation generates
replication problems remain elusive,
but an intriguing paper published last
year implicated the availability of
DNA building blocks in the process [2].
The authors induced oncogenic stress
in primary cells by deregulating the
Rb–E2F pathway, which normally
activates S phase. As expected, this
gave rise to severe S phase problems
manifested as shorter inter-origin
distances, slower fork progression
and massive formation of DSBs.
Interestingly, the authors found this
oncogenic S phase was accompanied
by a significant reduction in cellular
deoxynucleotide (dNTP) pools, possibly
due to the inability of the cells to
up-regulate nucleotide biosynthesis to
match the increased DNA replication
activity. Furthermore, the S phase
problems could largely be reversed
by exogenous supply of nucleosides.
Hence, this study suggests that the
correct supply of DNA building blocks
during S phase is important for genome
stabilityand for thepreventionofcancer.
Studies of the Spd1 protein in fission
yeast point in the same direction. Spd1,
a fascinating small, intrinsically
disordered protein (IDP) that we are
only beginning to understand the
molecular function of [3], was first
identified in a screen for genes that
inhibit S phase when over-expressed[4]. Subsequent studies showed that
cells get rid of their Spd1 protein via
ubiquitylation-mediated proteolysis
whenever they need to synthesize
DNA [5]. Spd1 degradation becomes
activated when cells enter S phase
by transcriptional induction of Cdt2,
a substrate adaptor for the E3 ubiquitin
ligase CRL4 [6]. CRL4–Cdt2 defective
cells therefore undergoDNA replication
in the presence of Spd1, and this
process is very similar to the oncogenic
S phase described above: replication
proceeds slowly, with concomitant
generation of DSBs and activation
of the ATR/Rad3 checkpoint [5,7,8].
Interestingly, the activation of (and
requirement for) a functional Rad3/ATR
pathway in CRL4–Cdt2 defective cells
is fully reversed by deletion of the spd1
gene, demonstrating that Spd1 is the
major CRL4–Cdt2 substrate causing
replication stress in fission yeast [5,7].
Cdt2 can also be induced to
down-regulate Spd1 during repair
synthesis by a Rad3/ATR-dependent
pathway [5,9]. Since its accumulation
in itself causes activation of the
Rad3/ATR pathway, Spd1 can
therefore trigger its own degradation.
But how does Spd1 inhibit S phase?
A first clue to its molecular target
came from the observation that the
phenotype associated with Spd1
accumulation is very similar to that
observed when treating cells with
hydroxyurea [4], a drug that causes
reduced production of dNTPs via
inhibition of the enzyme ribonucleotide
reductase (RNR). The type 1a class
of RNRs found in eukaryotes consists
of a heterotetramer composed of two
large catalytic R1 subunits, and two
small R2 subunits which generate
the tyrosyl free radical required for
catalysis [10]. Hydroxyurea inhibits
RNR function by acting as a scavenger
of this radical. Consistent with a role
for Spd1 in inhibiting RNR, CRL4–Cdt2
defective ddb1 cells have reduced
dNTP pools, and this effect is reversed
by spd1 loss [7]. Direct evidence linking
Spd1 to RNR inhibition was providedwhen Antony Carr’s lab reported that
the S phase problems associated with
Spd1 accumulation could be overcome
by overexpressing the small R2 subunit
(called Suc22 in fission yeast) [5].
Curiously, overexpression of the large
subunit (Cdc22) did not have a similar
effect [11]. Furthermore, it was reported
that in the presence of Spd1 the R2
subunit of RNR was kept in the cell
nucleus, away from the R1 subunit,
which ismainly cytoplasmic, potentially
providing a mechanism for RNR
inhibition [5,12]. However, subsequent
in vitro studies reported that Spd1
could also inhibit RNR activity directly
by binding to the large R1 subunit [13].
Scanning mutagenesis of the spd1
gene demonstrated that these two
RNR inhibitory effects could be
genetically separated, and that R1
inhibition rather than nuclear import
of R2was causing Rad3/ATR activation
in Spd1-accumulating cells [3]. The
biological significance of R2 nuclear
import is thus unclear, but recently it
has been proposed that RNR in
mammalian cells is activated directly
at sites of damage [14]. Interestingly,
in the distantly related budding yeast
Saccharomyces cerevisiae, the two
Spd1-related IPDs, Sml1 and Dif1, have
similarly been reported to, respectively,
inhibit R1 and sequester R2 to the
nucleus. Synteny analysis suggests
that these two genes arose by gene
duplication of a common ancestor with
both functions, similar to fission yeast
Spd1 [15]. Hence, Spd1-mediated RNR
repression is evolutionarily conserved,
at least in fungi. Finally, Nestoras et al.
[3] identified yet a third molecular
function of Spd1: when the R1 and R2
subunits are tagged with different
fluorescent proteins, a FRET
(fluorescence resonance energy
transfer) reaction is observed between
them, but only in cells expressing Spd1.
How the underlying conformational
change in RNR architecture affects
its activity is unknown.
A new paper from Stephen Kearsey’s
group, published in this issue of
Current Biology, reports that Spd1
degradation is linked to active
replication [16]. The paper presents
evidence that Spd1, similar to other
CRL4–Cdt2 substrates [17], requires
interaction with the polymerase
processivity factor PCNA in order to
become degraded. Inhibition of PCNA
loading onto DNA (by inactivation
of replication factor C), or prevention
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(by a point mutation in PCNA) both
abolish damage-induced Spd1
turnover. The authors identify
a somewhat degenerate PIP (PCNA
Interaction Protein)-degron in Spd1,
and provide genetic evidence that
this region is important for Spd1
turnover. Finally, by means of
bimolecular fluorescence
complementation (BiFC) it is shown
that Spd1 and PCNA can interact
in vivo, in a PIP-sequence-dependent
manner. Taken together, these
observations demonstrate that Cdt2
induction is necessary but not
sufficient for Spd1 proteolysis.
In addition, interaction of Spd1 with
PCNA is required to activate the
CRL4–Cdt2 E3 ligase, and this is only
possible when active replication
causes loading of PCNA onto DNA.
What is the biological function of
Spd1? We cannot exclude that the
protein is merely ensuring repression
of total dNTP production when DNA
synthesis is not taking place, but
perhaps Spd1 plays an important role
in targeting dNTP production to
replication and repair factories.
In general, the phenotypes associated
with excess Spd1 are much more
severe than those caused by Spd1 loss.
Elevated Spd1 levels (observed e.g. in
cdt2-deleted cells) cause a strong
checkpoint activation, presumably
signalled by single-stranded DNA
formation due to lowering of dNTP
pools upon RNR inhibition (although
it cannot be excluded that elevated
Spd1 levels may also cause checkpoint
activation by jamming other processes
at PCNA). In view of the new findings
of Salguero et al. [16], it is tempting
to speculate that an initial increase inSpd1 concentration caused by blocked
replication, e.g. after damage, might
contribute to checkpoint activation.
The activated checkpoint then would
cause Cdt2 induction [6] and repair
synthesis, which depends on PCNA
loading. The combination of the two
would drive Spd1 degradation to
provide dNTPs for repair synthesis
[9,16]. It is intriguing that S phase in the
presence of Spd1 in fission yeast
resembles replication stress imposed
by certain oncogenes in mammalian
cells, and it will be interesting to learn
if metazoan cells also modulate their
RNR activity by small IDPs. Yet, the
limited sequence conservation of this
interesting protein family has thus far
prevented their identification.References
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Obituary Prematurely Written?Studies on insect olfactory learning have established the mushroom bodies
as key brain structures for the formation of long-term memory (LTM). Two new
neurons in the fly brain are reported now as essential sites for LTM formation,
while mushroom bodies are claimed to be unnecessary to this end.Ronald L. Davis1 and Martin Giurfa2,3
Insects, with their remarkable learning
capacities and relatively simple andaccessible nervous systems, provide
powerful models for studying
associative learning and memory [1–4].
The combination of proceduresfor classical conditioning with the
disruptive methods of genetics has
made it possible to identify cellular
and molecular substrates of memory
in some species, such as the honey
bee Apis mellifera and the fruit fly
Drosophila melanogaster. These
studies established the mushroom
bodies, paired central structures in
the insect brain, as a key site for the
formation of long-term memories.
A recent study [5] of fruit fly learning
has attributed this role to two neurons
external to mushroom bodies and
